After Baclofen, now Gabapentin: Marksans Pharma arm bags another UK MHRA green light Ruchika Sharma15 May 2025 12:56 PM ISTMumbai: Marksans Pharma Limited has announced that its wholly owned subsidiary in the UK, Relonchem Limited, has received Marketing...
Merck scores USFDA OK for Welireg for 12 years and older with pheochromocytoma or paraganglioma Ruchika Sharma15 May 2025 11:45 AM ISTRahway: Merck, known as MSD outside of the United States and Canada, has received the approval from the U.S. Food and Drug Administration...
AbbVie Emrelis gets USFDA accelerated approval for a type of lung cancer Ruchika Sharma15 May 2025 11:10 AM ISTNorth Chicago: AbbVie has received accelerated approval from the U.S. Food and Drug Administration (FDA) for EMRELIS (telisotuzumab...
Shilpa Pharma Lifesciences Unit 1 gets EIR from USFDA Ruchika Sharma15 May 2025 10:15 AM ISTKarnataka: Shilpa Pharma Lifesciences, a 100% subsidiary of Shilpa Medicare Limited, has received an Establishment Inspection Report...
Andhra Pradesh CM unveils Bharat Biotech arm Lumpy Skin Disease vaccine Ruchika Sharma14 May 2025 6:01 PM ISTVijayawada: Chief Minister of Andhra Pradesh Shri N. Chandrababu Naidu has launched the indigenous Lumpy Skin Disease (LSD) vaccine BIOLUMPIVAXIN,...
Unichem Labs Pithampur facility gets USFDA EIR Ruchika Sharma14 May 2025 5:39 PM ISTMumbai: Unichem Labs has announced that United States Food and Drug Administration (USFDA) has classified the inspection at the Company's...
USFDA nod to generic therapeutic equivalent version of Janssen Pharma Haldol injection Ruchika Sharma14 May 2025 3:38 PM ISTChennai: Caplin Steriles Limited, a Subsidiary Company of Caplin Point Laboratories Limited, has received final approval from the...
GSK, partner iTeos end development programme for lung cancer drug belrestotug Ruchika Sharma14 May 2025 2:30 PM ISTGSK plc with its development partner iTeos Therapeutics, Inc., has announced that it is ending the development programme for experimental lung cancer...
Takeda gets UK nod for rare blood disorder treatment Ruchika Sharma14 May 2025 1:30 PM ISTTakeda UK Ltd. has received approval from the Medicines and Healthcare products Regulatory Agency (MHRA) for rADAMTS13 (ADZYNMA), a treatment to treat...
Lupin introduces kidney disease drug Tolvaptan in US Ruchika Sharma14 May 2025 12:27 PM ISTMumbai: Global pharma major Lupin Limited has announced the launch of Tolvaptan Tablets, 15 mg, 30 mg, 45 mg, 60 mg, and 90 mg in the United States,...
Aurobindo Pharma arm gets marketing authorisation in UK for Zefylti Ruchika Sharma14 May 2025 11:41 AM ISTHyderabad: CuraTeQ Biologics s.r.o., a wholly owned step-down subsidiary of Aurobindo Pharma Ltd, has obtained marketing authorisation from UK’s...
Hetero Labs gets CDSCO Panel nod to study Tegoprazan tablet 50 mg Dr. Divya Colin13 May 2025 5:45 PM ISTNew Delhi: Responding to the proposal presented by Hetero Labs, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
